These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 9231929

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide.
    Hoskin PJ, Rojas AM, Phillips H, Saunders MI.
    Cancer; 2005 Jun 01; 103(11):2287-97. PubMed ID: 15834926
    [Abstract] [Full Text] [Related]

  • 4. Radiotherapy and chemotherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme.
    Simon JM, Noël G, Chiras J, Hoang-Xuan K, Delattre JY, Baillet F, Mazeron JJ.
    Radiother Oncol; 2003 Apr 01; 67(1):45-51. PubMed ID: 12758239
    [Abstract] [Full Text] [Related]

  • 5. Carbogen and nicotinamide combined with unconventional radiotherapy in glioblastoma multiforme: a new modality treatment.
    Fatigante L, Ducci F, Cartei F, Colosimo S, Marini C, Prediletto R, Danesi R, Laddaga M, Del Tacca M, Caciagli P.
    Int J Radiat Oncol Biol Phys; 1997 Feb 01; 37(3):499-504. PubMed ID: 9112444
    [Abstract] [Full Text] [Related]

  • 6. Carbogen and nicotinamide in locally advanced bladder cancer: early results of a phase-III randomized trial.
    Hoskin PJ, Rojas AM, Saunders MI, Bentzen SM, Motohashi KJ, BCON investigators.
    Radiother Oncol; 2009 Apr 01; 91(1):120-5. PubMed ID: 18992952
    [Abstract] [Full Text] [Related]

  • 7. Short communication: the addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer.
    Pigott K, Dische S, Saunders MI.
    Br J Radiol; 1995 Feb 01; 68(806):215-8. PubMed ID: 7537598
    [Abstract] [Full Text] [Related]

  • 8. Long-Term Outcomes of Radical Radiation Therapy with Hypoxia Modification with Biomarker Discovery for Stratification: 10-Year Update of the BCON (Bladder Carbogen Nicotinamide) Phase 3 Randomized Trial (ISRCTN45938399).
    Song YP, Mistry H, Irlam J, Valentine H, Yang L, Lane B, West C, Choudhury A, Hoskin PJ.
    Int J Radiat Oncol Biol Phys; 2021 Aug 01; 110(5):1407-1415. PubMed ID: 33689854
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J.
    Radiother Oncol; 1996 Apr 01; 39(1):53-64. PubMed ID: 8735494
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
    Bussink J, Kaanders JH, Van der Kogel AJ.
    Acta Oncol; 1999 Apr 01; 38(7):875-82. PubMed ID: 10606417
    [Abstract] [Full Text] [Related]

  • 14. Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.
    Hoskin P, Rojas A, Saunders M.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1425-31. PubMed ID: 19036531
    [Abstract] [Full Text] [Related]

  • 15. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M.
    Radiother Oncol; 1993 Aug 01; 28(2):162-7. PubMed ID: 8248558
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 17. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
    Rojas A, Hirst VK, Calvert AS, Johns H.
    Int J Radiat Oncol Biol Phys; 1996 Jan 15; 34(2):357-65. PubMed ID: 8567336
    [Abstract] [Full Text] [Related]

  • 18. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ, Horsman MR, Siemann DW.
    Br J Cancer; 1993 Aug 15; 68(2):269-73. PubMed ID: 8347481
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma.
    Hoskin PJ, Rojas AM, Bentzen SM, Saunders MI.
    J Clin Oncol; 2010 Nov 20; 28(33):4912-8. PubMed ID: 20956620
    [Abstract] [Full Text] [Related]

  • 20. Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
    Miralbell R, Mornex F, Greiner R, Bolla M, Storme G, Hulshof M, Bernier J, Denekamp J, Rojas AM, Pierart M, van Glabbeke M, Mirimanoff RO.
    J Clin Oncol; 1999 Oct 20; 17(10):3143-9. PubMed ID: 10506611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.